Latest Partnerships News

MetalsTech Limited has completed a significant off-market block trade involving 4 million shares worth nearly $2 million, signaling notable shifts among its substantial shareholders.

Delorean Corporation has locked in a $14.5 million lower-cost loan facility with National Australia Bank to fund its SA1 Salisbury Bioenergy Project, refinancing existing debt and freeing capital for further bioenergy developments.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Hazer Group has been granted a pivotal patent in Singapore for its proprietary graphite morphology process, reinforcing its foothold in Southeast Asia's clean energy and advanced manufacturing markets.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.

Gumtree Australia Markets Limited has partnered with Australian Community Media to integrate automotive content, cross-list marketplace listings, and offer combined advertising solutions to a shared audience of 7.1 million Australians monthly.

Renergen Limited and Springbok Solar Power Plant have resolved a protracted legal dispute over land use rights, enabling both the Virginia Gas and Springbok Solar projects to operate collaboratively in South Africa's Free State.

Wellnex Life has secured a significant opening order from global partner Haleon for its Liquid Paracetamol and Ibuprofen softgel products in the UAE, marking the fourth national market in Haleon's distribution network. This milestone supports Wellnex's revenue forecasts for 2025 and underscores its strategic focus on innovative healthcare products.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.

Emyria secures a multi-year funding agreement with Medibank to support its Treatment-Resistant Depression program, marking a first for insurer-backed psychotherapy in Australia.